Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesCryoport Inc

Cryoport Inc

Industrials Integrated Freight & Logistics
PortfolioPortfolio WatchlistWatchlist
Company price
20.56 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
943582
Market Cap
534.74M

Momentum Score

…

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
20.47
Low
21.78
High
52 Week Price Range
5.31
Low
11.45
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cryoport Inc provides cryogenic cold-chain logistics and temperature-controlled supply chain solutions for biologics, cell and gene therapies, vaccines and diagnostic materials worldwide. Long-term growth is driven by rising global demand for advanced therapies, increasing commercial shipments of cell and gene products, and broader biologics commercialization; its specialized containers, continuous monitoring technology and logistics network may support recurring revenue and differentiation.

Principal risks include customer concentration and execution exposure in a capital-intensive, competitive cold-chain market, along with regulatory and quality-compliance obligations that investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
20.56
Dividend Yield
-
Revenue TTM
176.18M
Revenue Per Share
3.52
Gross Profit TTM
83.05M
Debt / Equity
0.46
ROE
-7.51%
Net Debt
-19.78M
ROCE
-6.74%
Diluted EPS TTM
-0.84

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -32.17M -99.35M -35.09M -35.09M -273.84M
Net income 70.30M -99.59M -37.33M -37.33M -275.53M
Selling general administrative 102.82M 148.98M 140.70M 120.06M 97.56M
Gross profit 83.05M 99.33M 103.87M 103.87M 96.58M
Reconciled depreciation 27.71M 30.76M 26.17M 22.77M 20.25M
Ebit -36.81M -93.84M -28.95M -31.90M -17.83M
Ebitda -11.65M -66.36M -6.19M -37.43M -20.65M
Depreciation and amortization 25.15M 27.49M 22.77M -5.52M -2.82M
Non operating income net other - - - - -251.32M
Operating income -36.81M -115.16M -31.90M -31.90M -17.83M
Other operating expenses 212.98M 348.41M 269.18M 269.18M 240.44M
Interest expense 2.36M 5.50M 6.14M 6.14M 4.69M
Tax provision 1.80M 1.28M 3.08M 2.24M 1.69M
Net interest income -2.36M -4.11M -5.65M -6.14M -4.69M
Income tax expense 1.80M 0.24M 2.24M 2.24M 1.69M
Total revenue 176.18M 233.25M 237.28M 237.28M 222.61M
Total operating expenses 119.86M 214.49M 135.78M 135.78M 114.41M
Cost of revenue 93.12M 133.92M 133.40M 133.40M 126.03M
Total other income expense net 4.64M 15.81M -3.19M -3.19M -256.01M
Net income from continuing ops -33.97M -114.76M -46.63M -37.33M -275.53M
Net income applicable to common shares - - - -45.33M -283.72M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 764.99M 703.49M 957.74M 1038.75M 1112.97M
Intangible assets 138.08M 170.46M 194.38M 191.01M 201.43M
Other current assets 8.42M 11.57M 10.08M 9.32M 8.80M
Total liab 262.35M 301.59M 468.72M 482.91M 471.14M
Total stockholder equity 502.64M 401.90M 489.02M 555.84M 641.83M
Other current liab 12.98M 16.94M 12.44M 8.46M 9.91M
Common stock 0.05M 0.05M 0.05M 0.05M 0.05M
Capital stock 42.33M 34.33M 26.32M 18.32M 10.32M
Retained earnings -688.88M -757.17M -642.42M -542.83M -467.54M
Other liab - - - 10.06M 5.04M
Good will 22.40M 51.66M 108.40M 151.12M 146.95M
Other assets - - 0.00M 1.96M 1.37M
Cash 250.49M 45.29M 46.35M 36.59M 139.10M
Total current liabilities 219.02M 64.56M 45.61M 40.85M 42.65M
Current deferred revenue 0.94M 1.11M 1.31M 0.44M 0.55M
Net debt -19.78M 205.41M 369.66M 399.31M 287.95M
Short term debt 189.81M 20.35M 5.81M 3.91M 3.60M
Short long term debt 185.26M 14.44M 0.15M 0.13M -
Short long term debt total 230.72M 250.70M 416.00M 435.91M 427.06M
Other stockholder equity 1152.68M 1145.68M 1131.18M 1114.90M 1100.29M
Property plant equipment - - - 90.48M 69.70M
Total current assets 476.17M 341.57M 535.11M 604.18M 693.52M
Net tangible assets - - - 195.44M 293.45M
Short term investments 160.71M 216.46M 410.41M 486.73M 489.70M
Net receivables 33.36M 45.78M 42.07M 43.86M 39.41M
Long term debt 1.09M 185.03M 379.89M 407.06M 405.26M
Inventory 23.19M 22.47M 26.21M 27.68M 16.50M
Accounts payable 15.28M 26.17M 26.05M 28.05M 28.58M
Accumulated other comprehensive income -3.48M -20.93M -26.07M -34.55M -1.24M
Common stock total equity - - - - 0.05M
Preferred stock total equity - - - - 10.28M
Retained earnings total equity - - - - -467.54M
Non currrent assets other 2.09M 2.90M 1.68M 1.02M 1.37M
Non current assets total 288.81M 361.92M 422.63M 434.57M 419.45M
Capital lease obligations 44.37M 51.23M 35.97M 28.72M 21.80M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 59.59M 176.81M 57.93M -59.68M -438.71M
Change to liabilities - - - -7.42M -0.07M
Total cashflows from investing activities 250.32M 176.81M 36.05M -59.68M -469.25M
Net borrowings -15.04M -164.32M -25.28M -3.26M 36.61M
Total cash from financing activities -21.07M -161.53M -23.80M -39.17M 564.34M
Change to operating activities - - - -2.66M 6.35M
Net income 70.30M -114.76M -99.59M -37.33M -275.53M
Change in cash 205.21M -1.06M 9.75M -102.51M 102.23M
Begin period cash flow 45.29M 46.35M 36.59M 139.10M 36.87M
End period cash flow 250.49M 45.29M 46.35M 36.59M 139.10M
Total cash from operating activities -8.58M -16.32M -0.76M -1.85M 8.13M
Issuance of capital stock - - 0.00M 0.00M 518.74M
Depreciation 27.71M 30.76M 27.49M 22.77M 20.25M
Other cashflows from investing activities 206.47M -4.33M -5.14M 3.00M -6.67M
Dividends paid 8.00M 8.00M 8.00M -8.00M -8.20M
Change to inventory -2.19M 3.25M 1.51M -14.20M -5.98M
Change to account receivables -6.53M -4.15M 3.67M -4.14M -7.27M
Sale purchase of stock -10.01M 0.00M 23.60M -37.96M 8.20M
Other cashflows from financing activities 8.00M 8.00M 1.48M 8.00M 297.97M
Change to netincome - - - 38.56M 269.13M
Capital expenditures 16.44M 17.25M 44.90M 24.20M 25.01M
Change receivables - - - - -7.27M
Cash flows other operating - - - - 4.24M
Cash and cash equivalents changes - - - - 103.21M
Change in working capital -14.36M -8.61M 0.78M -28.42M -6.96M
Stock based compensation 11.03M 19.70M 22.81M 20.08M 15.35M
Other non cash items -103.93M 56.58M 49.73M 20.11M 1.24M
Free cash flow -25.02M -33.58M -45.66M -26.05M -16.88M

Peer Comparison*

Sector: Industrials Industry: Integrated Freight & Logistics

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CYRX
Cryoport Inc		 -
-%		 20.56 - 70.42 3.04 1.15 2.21 -13.00
FDX
FedEx Corporation		 -
-%		 322.63 21.06 17.86 1.02 3.16 1.39 11.61
UPS
United Parcel Service Inc		 1.46
1.31%		 112.51 19.06 12.89 0.97 5.79 1.24 10.27
DHLGY
Deutsche Post AG		 0.41
1.24%		 33.36 16.10 15.72 0.78 2.52 0.95 7.03
DSDVY
DSV Panalpina A/S ADR		 1.65
1.54%		 108.97 48.35 24.63 0.26 3.46 1.99 20.03

Profile*

Cryoport Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

112 Westwood Place, Brentwood, TN, United States, 37027

949 470 2300

https://www.cryoportinc.com

684

Name Title Year Born
Mr. Jerrell W. Shelton Chairman, Pres & CEO 1945
Mr. Robert S. Stefanovich Sr. VP, CFO, Treasurer & Corp. Sec. 1965
Dr. Mark W. Sawicki Ph.D. Sr. VP & Chief Scientific Officer NA
Tony Ippolito VP & Gen. Counsel NA
Mr. Thomas J. Heinzen VP of Corp. Devel. NA
Mr. Bret Bollinger Chief Technology Officer of Cryoport Systems, LLC 1967
Mr. Phil Wilson Chief Operating Officer of Cryoport Systems, LLC NA
Mr. Raymond Takahashi M.D. Exec. Officer NA
Mr. David Petreccia M.D. Exec. Officer NA
Mr. Bret Bollinger VP & Chief Innovation Officer 1967

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…